White House (Re)commits to Pushing Drug Importation

A bipartisan bill that would have allowed the import of low-cost pharmaceuticals from Canada and Europe has been defeated by Big Pharma and the White House.
This post was published on the now-closed HuffPost Contributor platform. Contributors control their own work and posted freely to our site. If you need to flag this entry as abusive, send us an email.

My newspaper column last week was on the Obama administration's hideous flip-flop on the issue of drug importation, and the column and the ongoing reporting here at OpenLeft prompted a very solid story at the top of CNN Tonight's Friday broadcast. Watch it here:

As I said, it's a solid piece that looks at whether the White House political staff manipulated the FDA and/or doctored an official FDA safety warning in order to protect pharmaceutical profits. Sen. Byron Dorgan (D-ND), who made the allegation, has since stopped talking, likely under intense pressure from the White House and the drug industry. But we'll try to keep reporting out facts on this, as it's a huge story. Politicizing safety agencies a la Karl Rove is positively outrageous -- especially when it's all to protect a price cartel.

The good news is that the furor seems to have exacted a commitment out of the White House for future action:

Popular in the Community

Close

What's Hot